Skip to main content
. 2017 Feb 25;8(33):55567–55574. doi: 10.18632/oncotarget.15698

Table 3. Hematotoxicity according to common toxicity criteria (version 4.0) in all patients prior to and after 3 cycles of RLT.

Baseline After 3 cycles of RLT
CTC 0° (%) CTC 1° (%) CTC 2° (%) CTC 3° (%) CTC 0° (%) CTC 1° (%) CTC 2° (%) CTC 3° (%)
WBC 43 (87.8) 4 (8.2) 1 (2.0) 1 (2.0) 42 (85.7) 5 (10.2) 2 (4.1) 0 (0)
Hb 7 (14.3) 33 (67.3) 7 (14.3) 2 (4.1) 30 (61.2) 03 (6.1) 12 (24.5) 4 (8.2)
Plt 41 (83.7) 07 (14.3) 01 (2.0) 0 (0) 37 (75.5) 07 (14.3) 2 (4.1) 3 (6.1)*

There were no treatment-associated grade 4 or 5 toxicities.

Abbreviations: WBC: white blood cells, Hb: hemoglobin, Plt: platelets

* Two patients with grade 3 thrombocytopenia showed no anemia and one had grade 3 anemia